M&A Deal Summary |
|
|---|---|
| Date | 2025-10-15 |
| Target | JSR Life Sciences - Chromatography Business |
| Sector | Life Science |
| Buyer(s) | Merck |
| Sellers(s) | JSR Life Sciences |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1668 |
| Sector | Diversified |
| Employees | 64,011 |
| Revenue | 21.2B EUR (2024) |
Merck is a science and technology company in healthcare, life science, and performance materials. It develops technologies that improve and enhance life, from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Merck was founded in 1668 and is based in Darmstadt, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 26 of 26 |
| Sector: Life Science M&A | 12 of 12 |
| Type: Divestiture M&A Deals | 3 of 3 |
| State: California M&A | 3 of 3 |
| Country: United States M&A | 12 of 12 |
| Year: 2025 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-04-28 |
SpringWorks Therapeutics
Stamford, Connecticut, United States SpringWorks Therapeutics is a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer. SpringWorks Therapeutics was founded in 2017 and is based in Stamford, Connecticut. |
Buy | $3.9B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-11-06 |
Merck - OLED Patent Assets
Darmstadt, Germany Merck's OLED Patent Assets include more than 300 issued and pending patents worldwide, covering more than 110 unique patent families in the field of advanced OLED emissive device structures and related material components and are based in Darmstadt, Germany. |
Sell | - |
JSR Life Sciences Corp is provider of specialized materials and products to the biotech industry. JSR Life Sciences operates a network of manufacturing facilities, sales offices and R&D labs in key markets throughout North America, Europe and AsiaPacific. JSR Life Sciences is focused on diagnostics and research products and bioprocessing materials and services for the manufacture of biologics. JSR Life Sciences is based in Sunnyvale, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science M&A | 1 of 2 |
| Type: Divestiture M&A Deals | 1 of 2 |
| State: California M&A | 1 of 2 |
| Country: United States M&A | 1 of 2 |
| Year: 2025 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-06-14 |
Selexis SA
Ouates, Switzerland Selexis SA is a provider of an unparalleled proprietary technology and the highly-specialized expertise that is necessary to translate scientific innovation into life-saving medicines for patients. Selexis’ SUREtechnology Platform™ facilitates the rapid, stable, and cost-effective production of virtually any recombinant protein and provides seamless integration of the bioproduction continuum, spanning discovery to commercialization. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-11-13 |
CrownBio
San Diego, California, United States CrownBio is a preclinical contract research organization (CRO) focused on oncology, immuno-oncology, inflammation, cardiovascular, and metabolic disease drug discovery. The firm provides in vitro, in vivo, and translational biology platforms, including patient-derived xenograft (PDX) models, organoids, and bioinformatics to help biopharmaceutical companies advance therapeutic programs. CrownBio was founded in 2006 and is headquartered in San Diego, California. |
Sell | $204M |
